FR2230375A1 - Compsns. for use in prepg. agents for radiographic examn of bone - contg. phosphonates and chromous, ferrous or stannous chlorides or sulphates - Google Patents

Compsns. for use in prepg. agents for radiographic examn of bone - contg. phosphonates and chromous, ferrous or stannous chlorides or sulphates

Info

Publication number
FR2230375A1
FR2230375A1 FR7417966A FR7417966A FR2230375A1 FR 2230375 A1 FR2230375 A1 FR 2230375A1 FR 7417966 A FR7417966 A FR 7417966A FR 7417966 A FR7417966 A FR 7417966A FR 2230375 A1 FR2230375 A1 FR 2230375A1
Authority
FR
France
Prior art keywords
po3h2
chromous
radiographic
bone
ferrous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7417966A
Other languages
English (en)
French (fr)
Other versions
FR2230375B1 (de
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of FR2230375A1 publication Critical patent/FR2230375A1/fr
Application granted granted Critical
Publication of FR2230375B1 publication Critical patent/FR2230375B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0489—Phosphates or phosphonates, e.g. bone-seeking phosphonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7417966A 1973-05-23 1974-05-22 Compsns. for use in prepg. agents for radiographic examn of bone - contg. phosphonates and chromous, ferrous or stannous chlorides or sulphates Granted FR2230375A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36328673A 1973-05-23 1973-05-23

Publications (2)

Publication Number Publication Date
FR2230375A1 true FR2230375A1 (en) 1974-12-20
FR2230375B1 FR2230375B1 (de) 1978-07-21

Family

ID=23429614

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7417966A Granted FR2230375A1 (en) 1973-05-23 1974-05-22 Compsns. for use in prepg. agents for radiographic examn of bone - contg. phosphonates and chromous, ferrous or stannous chlorides or sulphates

Country Status (5)

Country Link
BE (1) BE815396A (de)
DE (1) DE2424496C3 (de)
FR (1) FR2230375A1 (de)
NL (1) NL7406953A (de)
ZA (1) ZA743158B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4364920A (en) * 1975-04-30 1982-12-21 Medi-Physics, Inc. Stable diagnostic reagents

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3735001A (en) * 1972-05-24 1973-05-22 Atomic Energy Commission Technetium bone scanning medium

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3735001A (en) * 1972-05-24 1973-05-22 Atomic Energy Commission Technetium bone scanning medium

Also Published As

Publication number Publication date
DE2424496C3 (de) 1980-05-22
DE2424496B2 (de) 1979-08-30
DE2424496A1 (de) 1974-12-12
BE815396A (fr) 1974-11-22
NL7406953A (de) 1974-11-26
FR2230375B1 (de) 1978-07-21
ZA743158B (en) 1975-05-28

Similar Documents

Publication Publication Date Title
TW326045B (en) N-alkyl-2-substituted ATP analogues the invention relates to a compound of formula (I) and its pharmaceutically acceptable salt which can be used for inhibition of platelet aggregation.
FI885623A0 (fi) Menetelmä lääkeaineina käyttökelpoisten substituoitujen propaani-fosfiinihappoyhdisteiden valmistamiseksi
ES8604143A1 (es) Un procedimiento para preparar 4-aminoalquil-2(3h)-indolonas
ES422884A1 (es) Procedimiento para retardar la descomposicion del peroxido de hidrogeno inducida por el hierro.
ES422885A1 (es) Procedimiento para preparar soluciones concentradas de pe- roxido de hidrogeno.
GB1503439A (en) Compositions for use in the production of 99m technetium radio-diagnostics
KR920000334A (ko) 방사성 약물의 제제,이들의 투여방법 및 제조방법
ES8106004A1 (es) Procedimiento para la preparacion de sales de rifamicina sv acuosolubles
FR2230375A1 (en) Compsns. for use in prepg. agents for radiographic examn of bone - contg. phosphonates and chromous, ferrous or stannous chlorides or sulphates
ES2073416T3 (es) Poliprenoles y fosfatos de poliprenilo para la inhibicion de metastasis de tumores.
GB1501827A (en) Composition for use in the production of 99m technetium radio-diagnostics
IL69292A (en) Muramyl peptides substituted by 1,2-diacylated-sn-glycero-3-hydroxyphosphoryl,their manufacture and pharmaceutical compositions containing them
FI950552A (fi) Permanenttauskoostumus ja menetelmä
DE69426244D1 (de) Einen für Tumore cytotoxischen Faktor enthaltende pharmazeutische Zusammensetzung
EG19218A (en) Stable solutions of rebeccamycin analogs and preparation thereof
DK1001944T3 (da) Pyrazinderivater, deres fremstilling samt medikamenter indeholdende disse forbindelser
FR2011940A1 (en) Compns contng cysteine cysteamine derivs for acne
DE3478787D1 (en) Composition for hair-treatment
MX9303827A (es) Composiciones antisarro.
GR852310B (de)
GB1469121A (en) Technetium-labelled complexes production and use thereof
GB1449443A (en) Fungicidal compositions containing disubstituted phosphonates
ES449421A1 (es) Procedimiento para preparar derivados de 2-dialquilamino- propano.
MX173052B (es) Anticongelante que contiene aceite, soluble en alcohol/insoluble en agua
USD234713S (en) Portable fluorescent light

Legal Events

Date Code Title Description
ST Notification of lapse